• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Research Report on Global and China Blood Product Industry, 2013-2017 Product Image

Research Report on Global and China Blood Product Industry, 2013-2017

  • Published: July 2013
  • Region: China
  • 60 Pages
  • China Research & Intelligence

Blood products are made by separating and extracting various proteins in plasma and classified into albumin products, immune globulin products, coagulation factor products and other blood products. China enterprises mainly produce nine kinds of products of the first three categories.

The concentration rate of global blood products is very high and the 5 enterprises of developed countries occupy 80-85% of the market. The global plasma volume in 2012 exceeded 30,000 tons and the market scale reached USD 17.5 billion, increasing by 7.4% YOY. The current global blood product market remains relatively stable, mainly driven by emerging economies.

There are strict regulations and high barriers to entry in China blood product industry. No new blood product manufacturing enterprises are allowed to be further established and the import of most blood product varieties is limited. By July 2013, there are only about 20 blood product manufacturers with normal production in China, with small annual plasma volumes and a low market concentration rate.

In 2012, China blood product enterprises realized a total plasma volume of 3,300 tons which decreased compared with that in 2011. READ MORE >

Chapter 1 Introduction of Blood Products
1.1 Definition
1.2 Classification
1.2.1 Albumin
1.2.2 Immune Globulin
1.2.3 Coagulation Factors
1.2.4 Other Categories
1.3 Characteristics of Blood Products

Chapter 2 Overview on Global Blood Product Industry, 2008-2012
2.1 Industry Overview
2.1.1 Development Process
2.1.2 Competition Pattern
2.1.3 Supply Status
2.1.4 Demand Status
2.2 Major Blood Product Manufacturers in the Globe
2.2.1 Baxter International
2.2.2 CSL Behring
2.2.3 Grifols SA

Chapter 3 Development Environment of China Blood Product Industry, 2008-2013
3.1 Economic Environment
3.2 Policy Environment
3.2.1 Competent Government Authorities
3.2.2 Policies on Enterprise Establishment
3.2.3 Policies on Raw Material Purchasing
3.2.4 Policies on Blood Product Production
3.2.5 Policies on Blood Product Circulation
3.3 Development Process
3.4 Barriers to Entry
3.4.1 Policy Barriers
3.4.2 Blood Source
3.4.3 Technology and Quality Control Capability

Chapter 4 Operation Status of China Blood Product Industry, 2008-2012
4.1 Overview
4. 1.1 Industry Status
4.1.2 Industry Characteristics
4.2 Supply
4.2.1 Production Status
4.2.2 China Blood Product Manufacturers
4.2.3 Production Capacity and Output Volume of Albumin
4.2.4 Production Capacity and Output Volume of Immune Globulin
4.2.5 Production Capacity and Output Volume of Coagulation Factors
4.3 Demand Status
4.3.1 Analysis on Demand Status of Albumin
4.3.2 Analysis on Demand Status of Immune Globulin
4.3.3 Analysis on Demand Status of Coagulation Factors

Chapter 5 Top 5 Enterprises of China Blood Product Industry, 2010-2012
5.1 China National Biotec Group
5.2 Hualan Biological Engineering Co., Ltd.
5.3 Beijing Tiantan Biological Products Co., Ltd.
5.4 Shanghai RAAS Blood Products Co. Ltd.
5.5 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.

Chapter 6 Prospect of China Blood Product Industry
6.1 Forecast on Supply
6.1.1 Forecast on Plasma Volume
6.1.2 Forecast on Lot Release
6.1.3 Forecast on Production Capacity Expansion
6.2 Forecast on Demand
6.2.1 Demand Trend
6.2.2 Forecast on the Overall Market Scale
6.2.3 Forecast on Segmented Market Scale
6.3 Industry Prospect
6.3.1 Forecast on Popular Products
6.3.2 Forecast on Competition Pattern
6.3.3 Mergers and Acquisitions

Selected Charts

Chart Common Varieties and Functions of Coagulation Factors
Chart Varieties and Functions of Other Blood Products
Chart Top 5 Blood Product Enterprises in the World, 2011-2012
Chart Global Blood Product Plasma Volume and Forecast, 2008-2017
Chart Global Blood Product Market Scale and Forecast, 2008-2017
Chart Sales Scale of Grifols SA's Blood Products, 2010-2012
Chart Important Policies of China Blood Product Industry Since 1985 and Influence
Chart Major Blood Product Manufacturers in China, 2012-2013
Chart Lot Release Volume of Albumin Products in China, 2008-2012
Chart Lot Release Volume of Immune Globulin Products in China, 2008-2012
Chart Lot Release Volume of Coagulation Factor Products in China, 2008-2012
Chart Market Scale of China Blood Products, 2008-2012
Chart Market Structure of China Blood Products, 2012
Chart Major Products of China National Biotec Group
Chart Plasma Volume of China National Biotec Group, 2009-2012
Chart Major Products of Hualan Biological Engineering Co., Ltd.
Chart Major Products of Beijing Tiantan Biological Products Co., Ltd.
Chart Plasma Volume of Beijing Tiantan Biological Products Co., Ltd., 2009-2012
Chart Plasma-Collecting Stations Newly Approved by the Chinese Government, 2009-2013
Chart Forecast on Plasma Volume in China, 2013-2017
Chart Forecast on Lot Release of China Blood Products, 2013-2017
Chart Comparison of Annual Blood Product Consumption Per Capita Between Developed Countries and China, 2012
Chart Forecast on the Market Scale of Blood Products in China, 2013-2017
Chart Forecast on the Market Scale of Albumin Products in China, 2013-2017
Chart Forecast on the Market Scale of Immune Globulin Products in China, 2013-2017
Chart Forecast on the Market Scale of Coagulation Factor Products in China, 2013-2017

- China National Biotec Group
- Hualan Biological Engineering Co., Ltd.
- Beijing Tiantan Biological Products Co., Ltd.
- Shanghai RAAS Blood Products Co. Ltd.
- Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.

Note: Product cover images may vary from those shown

ALSO AVAILABLE IN THE FOLLOWING LANGUAGES

RELATED PRODUCTS

Our Clients

Our clients' logos